Phosphorylated SATB1 is associated with the progression and prognosis of glioma

Cell Death and Disease

Volumn 4, Issue 10, 2013, Pages

  Han, S ^a   Xia, J ^a   Qin, X ^a   Wu, A ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Glioblastoma multiforme; Phosphorylation; Prognosis; Special AT rich sequence binding protein 1

Indexed keywords

GELATINASE A; GELATINASE B; HISTONE DEACETYLASE 1; MATRILYSIN; MESSENGER RNA; MICRORNA 155; REGULATOR PROTEIN; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; STROMELYSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN TISSUE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; FEMALE; GLIOBLASTOMA; GLIOMA CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO GENE TRANSFER; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR CELL LINE; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ASTROCYTOMA; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOPRECIPITATION; MATRIX ATTACHMENT REGION BINDING PROTEINS; PHOSPHORYLATION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84887461501     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.433     Document Type: Article

References (39)

1. Yan W, Zhang W, You G, Zhang J, Han L, Bao Z et al. Molecular classification of gliomas based on whole genome gene expression: A systematic report of 225 samples from the Chinese Glioma Cooperative Group. Neuro Oncol 2012; 14: 1432-1440
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA Cancer J Clin 2010; 60: 166-193
3. Zhang JX, Zhang J, Yan W, Wang YY, Han L, Yue X et al. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Neuro Oncol 2013; 15: 279-289
4. Rath BH, Fair JM, Jamal M, Camphausen K, Tofilon PJ. Astrocytes enhance the invasion potential of glioblastoma stem-like cells. PLoS One 2013; 8: E54752
5. Jia Z, Wang K, Wang G, Zhang A, Pu P. MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7. PLoS One 2013; 8: E55008
6. Romao LF, Mendes FA, Feitosa NM, Faria JC, Coelho-Aguiar JM, de Souza JM et al. Connective Tissue growth factor (CTGF/CCN2) Is negatively regulated during neuron-glioblastoma interaction. PLoS One 2013; 8: E55605
7. Lee HK, Bier A, Cazacu S, Finniss S, Xiang C, Twito H et al. MicroRNA-145 Is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS One 2013; 8: E54652
8. Huveldt D, Lewis-Tuffin LJ, Carlson BL, Schroeder MA, Rodriguez F, Giannini C et al. Targeting SRC family kinases inhibits bevacizumab-induced glioma cell invasion. PLoS One 2013; 8: E56505
9. Qi Q, He K, Liu X, Pham C, Meyerkord C, Fu H et al. Disrupting the PIKE-A/Akt interaction inhibits glioblastoma cell survival, migration, invasion and colony formation. Oncogene 2013; 32: 1030-1040
10. Wang Y, Moncayo G, Morin P Jr, Xue G, Grzmil M, Lino MM et al. Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme. Oncogene 2013; 32: 872-882
11. Galeano F, Rossetti C, Tomaselli S, Cifaldi L, Lezzerini M, Pezzullo M et al. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene 2013; 32: 998-1009
12. Cartron PF, Loussouarn D, Campone M, Martin SA, Vallette FM. Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme. Cell Death Dis 2012; 3: E421
13. Rampazzo E, Persano L, Pistollato F, Moro E, Frasson C, Porazzi P et al. Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death Dis 2013; 4: E500
14. Galande S, Purbey PK, Notani D, Kumar PP. The third dimension of gene regulation: organization of dynamic chromatin loopscape by SATB1. Curr Opin Genet Dev 2007; 17: 408-414
15. Beyer M, Thabet Y, Muller RU, Sadlon T, Classen S, Lahl K et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat Immunol 2011; 12: 898-907
16. McInnes N, Sadlon TJ, Brown CY, Pederson S, Beyer M, Schultze JL et al. FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. Oncogene 2012; 31: 1045-1054
17. Pavan KP, Purbey PK, Sinha CK, Notani D, Limaye A, Jayani RS et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell 2006; 22: 231-243
18. Jin H, Liang L, Liu L, Deng W, Liu J. HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells. J Cell Biochem 2013; 114: 1498-1509
19. Malatesta M, Steinhauer C, Mohammad F, Pandey DP, Squartrito M, Helin K. Histone acetyltransferase PCAF is required for Hedgehog-Gli-dependent transcription and cancer cell proliferation. Cancer Res 2013; 73: 6323-6333
20. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452: 187-193
21. Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu S et al. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 2010; 118: 855-863
22. Zhang J, Zhang B, Zhang X, Sun Y, Wei X, McNutt MA et al. SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo. PLoS One 2013; 8: E47902
23. Liu CX, Wen Y, Xu K, Zheng SB, Xu YW, Chen BS. Expression of special AT-rich sequence-binding protein in bladder urothelial carcinoma and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30: 1389-1391; 1394
24. Tan JA, Song J, Chen Y, Durrin LK. Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1. Mol Cell Biol 2010; 30: 2823-2836
25. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006; 9: 287-300
26. Margareto J, Leis O, Larrarte E, Idoate MA, Carrasco A, Lafuente JV. Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways. J Mol Neurosci 2007; 32: 53-63
27. Yamayoshi A, Yasuhara M, Galande S, Kobori A, Murakami A. Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer. Oligonucleotides 2011; 21: 115-121
28. Yang Z, Yuan XG, Chen J, Luo SW, Luo ZJ, Lu NH. Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: A novel mechanism of PTEN inactivation. Clin Res Hepatol Gastroenterol 2013; 37: 72-79
29. Bossuyt J, Ai X, Moorman JR, Pogwizd SM, Bers DM. Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure. Circ Res 2005; 97: 558-565
30. Sainz N, Rodriguez A, Catalan V, Becerril S, Ramirez B, Lancha A et al. Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice. PLoS One 2012; 7: E29389
31. Chu SH, Ma YB, Feng DF, Zhang H, Zhu ZA, Li ZQ et al. Upregulation of SATB1 is associated with the development and progression of glioma. J Transl Med 2012; 10: 149
32. Notani D, Limaye AS, Kumar PP, Galande S. Phosphorylation-dependent regulation of SATB1, the higher-order chromatin organizer and global gene regulator. Methods Mol Biol 2010; 647: 317-335
33. Barboro P, Repaci E, D'Arrigo C, Balbi C. The role of nuclear matrix proteins binding to matrix attachment regions (Mars) in prostate cancer cell differentiation. PLoS One 2012; 7: E40617
34. Iorns E, Hnatyszyn HJ, Seo P, Clarke J, Ward T, Lippman M. The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst 2010; 102: 1284-1296
35. Patani N, Jiang W, Mansel R, Newbold R, Mokbel K. The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int 2009; 9: 18
36. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996
37. Wan Y, Fei XF, Wang ZM, Jiang DY, Chen HC, Yang J et al. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chin J Cancer 2012; 31: 207-214
38. Wang C, Cao S, Yan Y, Ying Q, Jiang T, Xu K et al. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. BMC Cancer 2010; 10: 415
39. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999; 59: 793-797